Downregulation of RUNX1 was specifically noted in metastatic breast cancers, and attenuated expression of RUNX1 protein was reported in high-grade breast tumors when compared to low or mild-grade tumors [92,95,96]. This evidence concerns the gene RUNX1 and breast neoplasm.